MetaCap

Aytu BioPharma (AYTU) vs Caring Brands (CABR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Aytu BioPharma is the larger company by market cap ($22.3 million vs $12.0 million), about 1.9 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AYTU+3.54%CABR+39.26%
+98%+41%-16%
Nov 17, 20251 yearOct 8, 2026
AYTU+1.99%CABR+20.83%
+70%+24%-21%
Nov 17, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AYTU versus CABR key metrics
MetricAYTUCABR
Share price$2.05$1.16
Market cap$22.28M$12.03M
1-day change0.00%-4.92%
YTD return-21.15%+35.20%
1-year return-13.50%—
5-year return-96.13%—
Forward P/E13.23—
EPS (TTM)$-1.16$-0.82
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.07$1.84
52-week low$1.80$0.71
Distance from 52-week high-33.22%-36.96%
Analyst consensusstrong_buy—
Avg. price target upside+371.71%—
Average volume34.22K53.49K
Shares outstanding10.87M10.37M
Employees753
SectorHealthcareHealthcare
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Aytu BioPharma

AYTU stock →

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 15 years of age.

Healthcare · Drug Manufacturers - Specialty & Generic · 75 employees

About Caring Brands

CABR stock →

Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema).

Healthcare · Drug Manufacturers - Specialty & Generic · 3 employees

AYTU vs CABR FAQ

Which is bigger, Aytu BioPharma or Caring Brands?

Aytu BioPharma (AYTU) is larger, with a market capitalization of $22.28M compared with $12.03M for Caring Brands (CABR).

Are Aytu BioPharma and Caring Brands in the same industry?

Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

More comparisons